Hisense Debuts 116UXS and XR10, Advancing RGB MiniLED into a New Era at CES 2026

Hisense Debuts 116UXS and XR10, Advancing RGB MiniLED into a New Era at CES 2026

LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics and home appliances, unveiled the 116UXS RGB MiniLED TV and Laser Projector XR10 at CES 2026, placing display innovation at the center of its global...

ENGINEAI Robotics Technology Introduces the T800 Humanoid Robot at CES 2026

ENGINEAI Robotics Technology Introduces the T800 Humanoid Robot at CES 2026

Supporting industrial transformation through embodied intelligence LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- ENGINEAI Robotics Technology, a developer of embodied intelligence systems, showcased two flagship products at CES 2026. These included the...

TCL CSOT Shapes a Limitless Future of Displays at CES 2026

TCL CSOT Shapes a Limitless Future of Displays at CES 2026

TCL CSOT reveals a holistic product vision under its APEX philosophy, delivering industry-defining advancements in image fidelity, eye care, sustainable design, AI-driven innovation, and next-generation form factors. LAS VEGAS, Jan. 7, 2026...

Haikou Embraces New Opportunities as the Hainan Free Trade Port Accelerates Opening-Up

Haikou Embraces New Opportunities as the Hainan Free Trade Port Accelerates Opening-Up

HAIKOU, China, Jan. 5, 2026 /PRNewswire/ -- A news report from Haikou Municipal Bureau of Tourism, Culture, Radio, Television and Sports: As a key hub of the Hainan Free Trade Port, Haikou is advancing its opening-up and global engagement through...

CCTV+: Xi Outlines Main Directions for Developing New Quality Productive Forces

CCTV+: Xi Outlines Main Directions for Developing New Quality Productive Forces

BEIJING, Jan. 3, 2026 /PRNewswire/ -- Chinese President Xi Jinping has conducted in-depth fieldwork and inspections at the production frontline over the past year, outlining the breakthroughs and main directions for developing new quality productive...

Foreign Executive Witnesses Rise of Intelligent Manufacturing in east China's Jiangxi

Foreign Executive Witnesses Rise of Intelligent Manufacturing in east China's Jiangxi

YICHUN, China, Dec. 30, 2025 /PRNewswire/ -- A report from Jiangxi International Communication Center (JXICC): Since the beginning of the 14th Five-Year Plan, east of China's Jiangxi Province has firmly grasped the key task of achieving new-type...

RWA.LTD Launches Vietnam Market Expansion: Using Ho Chi Minh City as a Strategic Hub to Explore Southeast Asia Deployment Pathways for Non-Financial RWA

RWA.LTD Launches Vietnam Market Expansion: Using Ho Chi Minh City as a Strategic Hub to Explore Southeast Asia Deployment Pathways for Non-Financial RWA

HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Against the backdrop of real-world asset (RWA) digitization gradually moving from concept to practical application worldwide, Southeast Asia is emerging as a key frontier for the next wave of innovation and...

SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model

SK Telecom Unveils A.X K1, Korea's First 500B-Scale Hyperscale AI Model

SKT consortium conducts Korean government's 'Sovereign AI Foundation Model' project with A.X K1, positioning Korea for Global Top 3 AI Powers A.X K1: Korea's first 'Teacher Model' for smaller and specialized applications SK Telecom realizes AI as...

Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference

Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference

TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined...

Kazia Therapeutics Regains Full Nasdaq Listing Compliance

Kazia Therapeutics Regains Full Nasdaq Listing Compliance

Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 18
  • menu
    menu